Wegovy pill receives approval in Europe for obesity treatment

1 sourceFirst reported 5 days agoUpdated 5 days ago

AI summary: catch up in 20 seconds

The European Commission approved Wegovy® in a tablet form for the chronic treatment of obesity and overweight in adults on July 15, 2026.
Novo Nordisk announced that this approval opens a new chapter in obesity treatment.
The medication is intended for adults who have at least one related comorbidity.
Wegovy® is the first oral formulation of this treatment previously available only as an injection.
This approval reflects ongoing developments in addressing obesity-related health issues in Europe.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Το Wegovy σε χάπι παίρνει το «πράσινο φως» στην Ευρώπη -Μια νέα εποχή στη θεραπεία της παχυσαρκίαςiefimerida.gr · 5 days ago

In this storyEU Affairs

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

The European Commission approved Wegovy® in a tablet form for the chronic treatment of obesity and overweight in adults on July 15, 2026.
Novo Nordisk announced that this approval opens a new chapter in obesity treatment.
The medication is intended for adults who have at least one related comorbidity.
Wegovy® is the first oral formulation of this treatment previously available only as an injection.
This approval reflects ongoing developments in addressing obesity-related health issues in Europe.

Generated by AI from the 1 sources below · always verify with the originals